159 related articles for article (PubMed ID: 16714850)
1. Susceptibility of Mycobacterium tuberculosis strains to gatifloxacin and moxifloxacin by different methods.
Somasundaram S; Paramasivan NC
Chemotherapy; 2006; 52(4):190-5. PubMed ID: 16714850
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of fluoroquinolones against Mycobacterium tuberculosis.
Sulochana S; Rahman F; Paramasivan CN
J Chemother; 2005 Apr; 17(2):169-73. PubMed ID: 15920901
[TBL] [Abstract][Full Text] [Related]
3. Determination of critical concentrations of moxifloxacin and gatifloxacin for drug susceptibility testing of Mycobacterium tuberculosis in the BACTEC MGIT 960 system.
Isaeva Y; Bukatina A; Krylova L; Nosova E; Makarova M; Moroz A
J Antimicrob Chemother; 2013 Oct; 68(10):2274-81. PubMed ID: 23788475
[TBL] [Abstract][Full Text] [Related]
4. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
Kosowska-Shick K; Credito K; Pankuch GA; Lin G; Bozdogan B; McGhee P; Dewasse B; Choi DR; Ryu JM; Appelbaum PC
Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of various methods of susceptibility to ofloxacin in strains of Mycobacterium tuberculosis.
Sulochana S; Venkataraman P; Paramasivan CN
Indian J Med Res; 1999 Dec; 110():186-9. PubMed ID: 10701297
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
Oliveira AD; D'Azevedo PA; Francisco W
Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
[TBL] [Abstract][Full Text] [Related]
7. Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin.
Nosova EY; Bukatina AA; Isaeva YD; Makarova MV; Galkina KY; Moroz AM
J Med Microbiol; 2013 Jan; 62(Pt 1):108-113. PubMed ID: 23019190
[TBL] [Abstract][Full Text] [Related]
8. Comparative minimal inhibitory and mutant prevention drug concentrations of four fluoroquinolones against ocular isolates of Haemophilus influenzae.
Hedlin P; Blondeau JM
Eye Contact Lens; 2007 May; 33(3):161-4. PubMed ID: 17502752
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial efficacy of gatifloxacin and moxifloxacin with and without benzalkonium chloride compared with ciprofloxacin and levofloxacin against methicillin-resistant Staphylococcus aureus.
Blondeau JM; Borsos S; Hesje CK
J Chemother; 2007 Apr; 19(2):146-51. PubMed ID: 17434822
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of moxifloxacin activity in vitro against Mycobacterium tuberculosis, including resistant and multidrug-resistant strains.
Tortoli E; Dionisio D; Fabbri C
J Chemother; 2004 Aug; 16(4):334-6. PubMed ID: 15332706
[TBL] [Abstract][Full Text] [Related]
11. gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis.
Sirgel FA; Warren RM; Streicher EM; Victor TC; van Helden PD; Böttger EC
J Antimicrob Chemother; 2012 May; 67(5):1088-93. PubMed ID: 22357804
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibilities of bacterial isolates from conjunctival flora to gatifloxacin, levofloxacin, tosufloxacin, and moxifloxacin.
Yamada M; Hatou S; Yoshida J
Eye Contact Lens; 2008 Mar; 34(2):109-12. PubMed ID: 18327047
[TBL] [Abstract][Full Text] [Related]
13. Validation of the agar proportion and 2 liquid systems for testing the susceptibility of Mycobacterium tuberculosis to moxifloxacin.
Piersimoni C; Lacchini C; Penati V; Iona E; Fattorini L; Nista D; Zallocco D; Gesu GP; Codecasa L
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):283-7. PubMed ID: 17338942
[TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB.
Von Groll A; Martin A; Jureen P; Hoffner S; Vandamme P; Portaels F; Palomino JC; da Silva PA
Antimicrob Agents Chemother; 2009 Oct; 53(10):4498-500. PubMed ID: 19687244
[TBL] [Abstract][Full Text] [Related]
15. Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the VITEK 2 instrument.
Jorgensen JH; Crawford SA; McElmeel LM; Whitney CG
J Clin Microbiol; 2004 Dec; 42(12):5928-30. PubMed ID: 15583344
[TBL] [Abstract][Full Text] [Related]
16. Benzalkonium chloride enhances antibacterial activity of gatifloxacin and reduces its propensity to select for fluoroquinolone-resistant strains.
Hesje CK; Borsos SD; Blondeau JM
J Ocul Pharmacol Ther; 2009 Aug; 25(4):329-34. PubMed ID: 19650708
[TBL] [Abstract][Full Text] [Related]
17. Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in Mycobacterium tuberculosis.
Coeck N; de Jong BC; Diels M; de Rijk P; Ardizzoni E; Van Deun A; Rigouts L
J Antimicrob Chemother; 2016 May; 71(5):1233-40. PubMed ID: 26851609
[TBL] [Abstract][Full Text] [Related]
18. High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile.
Drudy D; Quinn T; O'Mahony R; Kyne L; O'Gaora P; Fanning S
J Antimicrob Chemother; 2006 Dec; 58(6):1264-7. PubMed ID: 17018563
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility testing of clinical isolates of pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating pseudomonas ocular infections.
Epstein SP; Bottone EJ; Asbell PA
Eye Contact Lens; 2006 Sep; 32(5):240-4. PubMed ID: 16974157
[TBL] [Abstract][Full Text] [Related]
20. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
Kowalski RP; Dhaliwal DK; Karenchak LM; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
